Views
Graph
Explorer
Focus
Down
Load 1 level
Load 2 levels
Load 3 levels
Load 4 levels
Load all levels
All
Dagre
Focus
Down
Load 1 level
Load 2 levels
Load 3 levels
Load 4 level
Load all levels
All
Tree
SpaceTree
Focus
Expanding
Load 1 level
Load 2 levels
Load 3 levels
Down
All
Down
Radial
Focus
Expanding
Load 1 level
Load 2 levels
Load 3 levels
Down
All
Down
Box
Focus
Expanding
Down
Up
All
Down
Page ✓
Article
Outline
Document
Down
All
Canvas
Time
Timeline
Calendar
Request email digest
Past 24 hours
Past 2 days
Past 3 days
Past week
Add
Add page
Add comment
Add citation
Edit
Edit page
Delete page
Share
Link
Bookmark
Embed
Social media
Login
Member login
Register now for a free account
🔎
Heavy regulation may distort the balance of risk and reward
Komponentas
1
#88286
Immediately related elements
How this works
-
Emerging Technology Governance Project »
Emerging Technology Governance Project
Emerging Technology Governance Project☜This map is the start of our project on Emerging Technology Governance and explores the output of our first multi-stakeholder brainstorm and a debate which took place on our website and blog around the World Economic Forum definition of What is an Emerging Technology.☜F1CEB7
▲
Emerging technology governance issues? »
Emerging technology governance issues?
Emerging technology governance issues?☜The topics explored in the group brainstorm so far.☜FFB597
▲
Challenges for governance? »
Challenges for governance?
Challenges for governance?☜What the are challenges for the governance of emerging technologies (includiing the goverance challenges of technology in general).☜FFB597
▲
Risk of being technology averse »
Risk of being technology averse
Risk of being technology averse☜☜59C6EF
■
Heavy regulation may distort the balance of risk and reward
Heavy regulation may distort the balance of risk and reward☜☜9FDEF6
●
Regulatory burden on the pharmaceutical industry »
Regulatory burden on the pharmaceutical industry
Regulatory burden on the pharmaceutical industry☜For example if we follow the regulatory approach we have with the pharma industry and the huge cost of bringing pharmaceutical drugs to market are we pricing the risk effectively in relation to the potential benefit?’☜98CE71
Heading
Summary
Click the button to enter task scheduling information
Open
Details
Enter task details
Message text
Select assignee(s)
Due date (click calendar)
RadDatePicker
RadDatePicker
Open the calendar popup.
Calendar
Title and navigation
Title and navigation
<<
<
July 2024
>
<<
July 2024
S
M
T
W
T
F
S
27
30
1
2
3
4
5
6
28
7
8
9
10
11
12
13
29
14
15
16
17
18
19
20
30
21
22
23
24
25
26
27
31
28
29
30
31
1
2
3
32
4
5
6
7
8
9
10
Reminder
No reminder
1 day before due
2 days before due
3 days before due
1 week before due
Ready to post
Copy to text
Enter
Cancel
Task assignment(s) have been emailed and cannot now be altered
Lock
Cancel
Save
Comment graphing options
Choose comments:
Comment only
Whole thread
All comments
Choose location:
To a new map
To this map
New map options
Select map ontology
Options
Standard (default) ontology
College debate ontology
Hypothesis ontology
Influence diagram ontology
Story ontology
Graph to private map
Cancel
Proceed
+Komentarai (
0
)
- Komentarai
Komentuoti
Newest first
Oldest first
Show threads
+Citavimą (
0
)
- Citavimą
Pridėti citatą
List by:
Citerank
Map
+About
- About
Redagavo:
David Price
NodeID:
#88286
Node type:
Component
Įvedimo data (GMT):
1/11/2011 10:08:00 AM
Paskutinės redakcijos data (GMT laikas):
1/11/2011 10:08:00 AM
Show other editors
Įeinančios sąsajos:
0
Išeinančios sąsajos:
0
Vidutinis vertinimas:
0
by
0
vartotojai
x
Select file to upload